Alps Advisors Inc Lannett CO Inc Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$3.43 - $6.19 $236,128 - $426,131	-68,842 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$4.75 - $14.5 $64,961 - $198,302	13,676 Added 24.79%	68,842 $327,000
Q2 2018 Aug 02, 2018	BUY	$13.3 - $17.45 $178,579 - $234,301	13,427 Added 32.17%	55,166 $750,000
Q2 2018 Jul 25, 2018	SELL	$13.3 - $17.45 $119,939 - $157,364	-9,018 Reduced 17.77%	41,739 $968,000
Q1 2018 May 01, 2018	BUY	$14.7 - $24.95 $132,564 - $224,999	9,018 Added 21.61%	50,757 $815,000
Q4 2017 Feb 05, 2018	BUY	$19.9 - $29.25 $62,386 - $91,698	3,135 Added 8.12%	41,739 $968,000
Q3 2017 Nov 03, 2017	BUY	$15.1 - $19.25 $582,920 - $743,127	38,604	38,604 $712,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.